Cargando…
Phosphodiesterase type 5 inhibitors for the treatment of post-nerve sparing radical prostatectomy erectile dysfunction in men
Prostate cancer (PCa) is the most common solid neoplasm diagnosed in developed countries. Nerve-sparing radical prostatectomy (NS-RP) has been widely accepted as the best choice treatment for localised PCa. However, erectile dysfunction (ED) and urinary incontinence are commonly observed after NS-RP...
Autores principales: | Li, Jinhong, Shi, Qingquan, Pu, Chunxiao, Tang, Yin, Bai, Yunjin, Yuan, Haichao, Li, Xiang, Dong, Qiang, Wei, Qiang, Yuan, Jiuhong, Han, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107345/ https://www.ncbi.nlm.nih.gov/pubmed/25052550 http://dx.doi.org/10.1038/srep05801 |
Ejemplares similares
-
Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy: A network meta-analysis
por: Yang, Jie, et al.
Publicado: (2021) -
Systematic Review and Meta-Analysis of the Use of Phosphodiesterase Type 5 Inhibitors for Treatment of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy
por: Wang, Xiao, et al.
Publicado: (2014) -
Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis
por: Goh, Hyeok Jun, et al.
Publicado: (2022) -
Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction
por: Park, Yong Hyun, et al.
Publicado: (2016) -
AB023. Penile rehabilitation with phosphodiesterase type 5 inhibitors in men after nerve-sparing radical prostatectomy
por: Jiann, Bang-Ping
Publicado: (2016)